{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:08:00Z","timestamp":1760144880421,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cjca.2022.05.012","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:41:46Z","timestamp":1652874106000},"page":"1147-1149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ICDs for Patients With Stable VT, Cardiomyopathy, and Relatively Preserved LVEF: Core Therapy, Precision Medicine, or Indication Creep?"],"prefix":"10.1016","volume":"38","author":[{"given":"L. Brent","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek V.","family":"Exner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2022.05.012_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cpcardiol.2015.01.002","article-title":"Sudden cardiac death","volume":"40","author":"Kuriachan","year":"2015","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cjca.2022.05.012_bib2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2022.05.012_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10840-014-9913-z","article-title":"Adverse events following implantable cardioverter defibrillator implantation: a systematic review","volume":"40","author":"Persson","year":"2014","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2022.05.012_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/M17-0120","article-title":"Implantable cardioverter-defibrillators for primary prevention in patients with ischemic or nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"167","author":"Ko\u0142odziejczak","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2022.05.012_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/oxfordjournals.eurheartj.a059559","article-title":"The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction","volume":"10","author":"Brugada","year":"1989","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2022.05.012_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0735-1097(96)00123-4","article-title":"What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?","volume":"28","author":"Sarter","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.05.012_bib7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0002-8703(99)70412-6","article-title":"ESVEM Investigators: Clinical significance of syncope in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial","volume":"137","author":"Olshansky","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2022.05.012_bib8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0002-9149(93)90831-V","article-title":"Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation","volume":"71","author":"Olson","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2022.05.012_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/hrt.73.2.158","article-title":"Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest","volume":"73","author":"B\u00f6cker","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/j.cjca.2022.05.012_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1540-8167.2004.03344.x","article-title":"Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia","volume":"15","author":"Glikson","year":"2004","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2022.05.012_bib11","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2022.05.012_bib12","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.05.012_bib13","first-page":"174","article-title":"Canadian Cardiovascular Society\/Canadian Heart Rhythm Society 2016 implantable cardioverter defibrillator guidelines","volume":"33","author":"Bennett","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.05.012_bib14","first-page":"822","article-title":"2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society position statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease","volume":"36","author":"Deyell","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.05.012_bib15","first-page":"1271","article-title":"Hemodynamically tolerated ventricular tachycardia with mildly impaired ejection fraction: do these patients have VT\/VF recurrence and ICD therapies?","volume":"38","author":"Gula","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.05.012_bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.hrthm.2016.01.019","article-title":"Impact of revascularization in patients with sustained ventricular arrhythmias, prior myocardial infarction, and preserved left ventricular ejection fraction","volume":"13","author":"Mond\u00e9sert","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2022.05.012_bib17","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X22003208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X22003208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:48:26Z","timestamp":1760107706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X22003208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0828282X22003208"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2022.05.012","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ICDs for Patients With Stable VT, Cardiomyopathy, and Relatively Preserved LVEF: Core Therapy, Precision Medicine, or Indication Creep?","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2022.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2022.03.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}